Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06921239 | NOT YET RECRUITING | HLA Antibodies

HLA Antibodies in Systemic Lupus Erythematosus
Sponsor:

University hospital center, Amiens

Brief Summary:

Patients suffering from autoimmune diseases show false-positive results when anti-HLA antibodies are identified. This false positivity makes it difficult to obtain an organ transplant based on immunological compatibility (absence of anti-HLA antibodies directed against graft antigens). The objectives of this project are to study the prevalence of these false positivities in a population of lupus patients, and to evaluate biological tests that can negate these false positivities.

Condition or disease

HLA Antibodies

Systemic Lupus Erythematosus

Study Type : OBSERVATIONAL
Estimated Enrollment : 30 participants
Official Title : HLA Antibodies in Systemic Lupus Erythematosus
Actual Study Start Date : 2025-05
Estimated Primary Completion Date : 2025-11
Estimated Study Completion Date : 2026-05

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Patients Adults
  • * Followed in the internal medicine department of Amiens University Hospital - With systemic lupus erythematosus
  • * Without HLA immunization risk factors (no history of pregnancy, transfusions or transplants)
  • * With sera stored in the biobank
Exclusion Criteria
  • * minor Patients
  • * Opposing the re-use of their personal data for research purposes
HLA Antibodies in Systemic Lupus Erythematosus

Location Details

NCT06921239

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

Not yet recruiting

France,

Chru Amiens

Amiens, France, 80054